Sideline Gold on Fe...
Health Care: Drugs
AVANIR Pharmaceuticals (AVNR: NASDAQ)
$4.62 0.10 | 2.10%
06/18/13 - 04:00 PM ET
3.02M / 1.55M
Vol / Avg. Vol:4.51 / 4.52
Open / Prev. Close:4.33 - 4.62
Today's Range:2.07 - 4.78
52 Wk Range:71.98%
Performance YTD:TheStreet Rating:
Portfolios with AVNR
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Most Shorted Stocks in B...
- Contributor5 Stocks Under-$10 Setting ...
- Contributor5 Biotech Drug-Launch Stock...
- ContributorBreakout Stocks Of The Week...
- UserMy Portfolio
- Contributor6 Heavily Shorted Stocks 04...
Latest AVNR Headlines from TheStreet
- Arena Pharmaceuticals And 6 More Stocks To Watch 01.07.13 | 07:01 pm
- 5 Stocks Facing an Earnings Short Squeeze 12.10.12 | 12:12 pm
- 5 Stocks Under $10 Set to Soar Higher 08.30.12 | 12:08 pm
- Avanir Pharmaceuticals' CEO Presents At Canaccord Genuity 32nd Annual Growth Conference (Transcript) 08.14.12 | 02:08 pm
- Avanir Pharmaceuticals' CEO Discusses F3Q12 Results - Earnings Call Transcript 08.08.12 | 09:08 pm
- Avanir Pharmaceuticals CEO Presents At Bank Of America Merrill Lynch Health Care Conference (Transcript) 05.17.12 | 05:05 pm
- Avanir Pharmaceuticals' Presents At Deutsche Bank Securities Annual Health Care Conference (Transcript) 05.09.12 | 11:05 pm
- Avanir Pharmaceuticals' CEO Discusses F2Q2012 Results - Earnings Call Transcript 05.08.12 | 03:05 pm
- Avanir's CEO Presents At Citi 2012 Global Health Care Conference - Transcript 02.29.12 | 01:02 pm
- AVANIR Pharmaceuticals' CEO Discusses F1Q12 Results - Earnings Call Transcript 02.07.12 | 10:02 pm
Press Releases for AVNR
- Avanir Pharmaceuticals Announces Accelerated Development Path For AVP-786 Following Successful Pre-IND Meeting With FDA - PR Newswire 06.05.13 | 08:06 am
- Record Use Of At-the-Market (ATM) Offerings Continues In 2013 With $161 Million Raised By U.S. Life Sciences Companies In First Quarter, Reports Brinson Patrick - PR Newswire 05.28.13 | 08:05 am
- Avanir Pharmaceuticals To Participate In Two Upcoming Investor Conferences - PR Newswire 05.22.13 | 09:05 am
- Avanir Pharmaceuticals Announces Date Of Fiscal 2013 Second Quarter Financial Results And Conference Call - PR Newswire 05.01.13 | 08:05 am
- Avanir Pharmaceuticals Receives Positive CHMP Opinion For Approval Of NUEDEXTA In Europe - PR Newswire 04.26.13 | 07:04 am
- Avanir Pharmaceuticals Announces Appointment Of Corinne Nevinny To Board Of Directors - PR Newswire 03.11.13 | 04:03 pm
- AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY - PR Newswire 03.06.13 | 09:03 am
- AVANIR Pharmaceuticals To Paticipate In Two Conferences In March - PR Newswire 03.01.13 | 09:03 am
- Avanir Pharmaceuticals To Present At RBC Capital Markets' 2013 Global Healthcare Conference - PR Newswire 02.14.13 | 04:02 pm
- Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786 - PR Newswire 02.07.13 | 08:02 am
Partner Headlines for AVNR
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- After-Hours Earnings Report for December 12, 2012 : AVNR, INTL - NASDAQ 12.12.12 | 07:12 pm
- Neuralstem Swinging For The ALS Fences - Seeking Alpha 10.29.12 | 09:10 am
- Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel ... - GuruFocus 06.30.12 | 11:06 am
- Ultimate Stock Watch List for The Supreme Court's Health Care Ruling - Benzinga 06.28.12 | 09:06 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- Avanir Pharmaceuticals: Limelight On The Horizon - Seeking Alpha 02.17.12 | 06:02 am
- Canaccord Reiterates Buy, $6 PT on Avanir Pharmaceuticals - Benzinga 11.30.11 | 09:11 am
- Avanir - Closing Short Position - Seeking Alpha 11.27.11 | 08:11 am
- 10 Small-Cap Stocks Deeply Undervalued By Target Price - Seeking Alpha 11.11.11 | 10:11 pm
